Navigation Links
MedImmune's Brian Rosen Honored by Montgomery County Chamber at 49th Annual Awards Dinner
Date:6/6/2008

GAITHERSBURG, Md., June 6 /PRNewswire/ -- MedImmune, the global biologics unit of AstraZeneca, announced today that the Montgomery County Chamber of Commerce has presented Brian Rosen, senior director, government affairs, with its 2008 Chairman's Award at the organization's 49th Annual Dinner held recently at the Bethesda North Marriott Hotel and Conference Center.

"The Montgomery County Chamber of Commerce plays a vital role in representing the local business community at the regional and state levels, which is why MedImmune is proud to be an active corporate member," said Lori Weiman, vice president of public affairs. "We are pleased that the chamber has chosen to recognize Brian's commitment to its organization with the chairman's award."

The Montgomery County Chamber of Commerce Annual Chairman's Award recognizes an individual for outstanding service and contributions to the business community. Mr. Rosen has represented MedImmune as a board member of the Montgomery County Chamber for the past five years. He is currently the co-chair for the legislative affairs committee and a member of the executive committee and the board of directors.

About MedImmune

MedImmune is wholly owned by AstraZeneca plc (LSE: AZN.L, NYSE: AZN) and is the worldwide biologics business for the AstraZeneca Group. The company has approximately 3,000 employees worldwide and is headquartered in Gaithersburg, Maryland. MedImmune strives to provide better medicines to patients, new medical options for physicians and rewarding careers to employees. Dedicated to advancing science and medicine to help people live better lives, the company is focused on infection, oncology, respiratory disease and inflammation, cardiovascular/gastrointestinal disease and neuroscience. For more information, visit MedImmune's website at http://www.medimmune.com.


'/>"/>
SOURCE MedImmune
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Brian J.G. Pereira, M.D. Joins Biodels Board of Directors
2. MiMedx Announces Brian J. Splan as President
3. Clinical and Economical Considerations For IV Push Drug Delivery by Industry Expert Richard Rosenfeld Is Now Accessible on Expert411.com for Media and Professional Use
4. Dr Michael Rosenblatt Appointed Non-Executive Director at Shire
5. Nanotube production leaps from sooty mess in test tube to ready formed chemical microsensors
6. DuPont, Genencor International and Tate & Lyle Honored for Groundbreaking Work in Developing Bio-PDO(TM)
7. Aflac Honored with Corporate Citizenship Award
8. Dr. Dinesh Verma to be honored with Presidents Leadership Award at Edwin A. Stevens Society Gala
9. WuXi PharmaTech (NYSE: WX) CEO Honored among the 2007 China Top 10 Influential Entrepreneurs
10. Logical Therapeutics Co-Founder and CEO Honored with a Distinguished Investigator Award from the American College of Critical Care Medicine
11. PNAS paper and its authors honored for scientific excellence
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... , ... October 10, 2017 ... ... cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing ... HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s ...
(Date:10/10/2017)... ... October 10, 2017 , ... Dr. Bob Harman, founder and CEO ... Diego Rotary Club. The event entitled “Stem Cells and Their Regenerative ... attendees. Dr. Harman, DVM, MPVM was joined by two human doctors: Peter B. ...
(Date:10/10/2017)... , Oct. 10, 2017 SomaGenics announced ... the NIH to develop RealSeq®-SC (Single Cell), expected to ... profiling small RNAs (including microRNAs) from single cells using ... highlights the need to accelerate development of approaches to ... "New techniques for measuring levels of ...
(Date:10/10/2017)... ... October 10, 2017 , ... The Pittcon Program Committee ... honoring scientists who have made outstanding contributions to analytical chemistry and applied ... the world’s leading conference and exposition for laboratory science, which will be held ...
Breaking Biology Technology:
(Date:4/5/2017)... LONDON , April 4, 2017 KEY ... is anticipated to expand at a CAGR of 25.76% ... neurodegenerative diseases is the primary factor for the growth ... full report: https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The ... of product, technology, application, and geography. The stem cell ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/30/2017)... 30, 2017 The research team of The ... (3D) fingerprint identification by adopting ground breaking 3D fingerprint minutiae recovery ... of speed and accuracy for use in identification, crime investigation, immigration ... ... A research team ...
Breaking Biology News(10 mins):